l e t t e r S Myeloid-derived suppressor cells (MDSCs) are pathologically activated and relatively immature myeloid cells that have been implicated in the immunological regulation of many pathologic conditions 1,2 . Phenotypically and morphologically, MDSCs are similar to neutrophils (PMN-MDSCs) and monocytes (M-MDSCs). However, they have potent suppressive activity and distinct gene expression profiles and biochemical characteristics 3 . No or very few MDSCs are observed in steadystate physiological conditions. Therefore, until recently, accumulation of MDSCs was considered a consequence of pathological processes or pregnancy. Here, we report that MDSCs with a potent ability to suppress T cells are present during the first weeks of life in mice and humans. MDSC suppressive activity was triggered by lactoferrin and mediated by nitric oxide, PGE2, and S100A9 and S100A8 proteins. MDSCs from newborns had a transcriptome similar to that of tumor MDSCs, but with strong upregulation of an antimicrobial gene network, and had potent antibacterial activity. MDSCs played a critical role in control of experimental necrotizing enterocolitis (NEC) in newborn mice. MDSCs in infants with very low weight, who are prone to NEC, had lower MDSC levels and suppressive activity than did infants with normal weight. Thus, the transitory presence of MDSCs may be critical for regulation of inflammation in newborns.
Although MDSCs are largely absent in healthy adults, recent evidence has indicated that MDSCs may play a role in the maintenance of maternal-fetal tolerance 4 . The roles of MDSCs in pregnancy appear to be consistent with a myeloid-cell response to partial genetic incomparability between mother and child. In this study, we tested the possible roles of MDSCs in steady-state conditions during the first weeks of life.
Populations of myeloid cells were evaluated in the spleens and bone marrow (BM) of adult mice (AM; 6-8 weeks of age), newborn mice (NBM), and adult mice within 7 d after giving birth (postpartum mice, PM). In comparison to AM and PM, 7-to 10-d-old NBM had substantially more splenic CD11b + Ly6C hi Ly6G − monocytes and CD11b + Ly6C lo Ly6G + neutrophils (Supplementary Fig. 1a ). Cells from NBM and AM had similar morphology ( Supplementary  Fig. 1b ). The proportion of these populations was highest on day 1 after birth and gradually decreased to levels comparable to those in AM by the end of week 2 (Fig. 1a) . The population of spleen macrophages was not different, whereas dendritic cells were lower in NBM than AM (Supplementary Fig. 1c) . In contrast to those in AM, monocytes from 7-to 10-d-old NBM potently inhibited proliferation of CD4 + and CD8 + T cells (Fig. 1b) , and neutrophils demonstrated potent suppression of antigen-specific proliferation of CD8 + T cells ( Fig. 1c) . Thus, these cells fit the criteria of M-MDSCs and PMN-MDSCs, respectively 3 . In NBM, MDSC suppressive activity was not observed during the first 3 d and disappeared after day 14 ( Fig. 1d,e ). Spleen macrophages did not have suppressive activity ( Supplementary  Fig. 1d ). In lactating PM, the number of monocytes and neutrophils did not differ from that in AM, and no suppressive activity was detected ( Supplementary Fig. 1e-h) . Thus, MDSCs were found exclusively in NBM.
To assess the ability of NBM MDSCs to control autoimmune inflammation, AM were sensitized and challenged with intranasal administration of ovalbumin (OVA) (Supplementary Fig. 2a ). Administration of NBM MDSCs, but not AM neutrophils, decreased lung inflammation ( Supplementary Fig. 2b,c) , the presence of leukocytes, and the amounts of IL-13 and IL-4 in bronchoalveolar lavage ( Supplementary  Fig. 2d-g) , and IgE in sera (Supplementary Fig. 2h ).
CD11b + Ly6C lo Ly6G + and CD11b + Ly6C hi Ly6G − cells from the spleens of AM and 7-d-old NBM were sorted, and whole transcriptome analysis was performed through RNA-seq ( Supplementary  Fig. 3a ). Ingenuity Pathway Analysis (IPA) revealed upregulation of 55 key transcriptional regulators in NBM including lactoferrin (Ltf), S100a8, and S100a9. Prostaglandin E synthase (Ptges) was upregulated in PMN-MDSCs. Ptges controls synthesis of the prostaglandin PGE2, Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation which has been implicated in MDSC function 5, 6 ( Supplementary  Fig. 3b ). In a previous study, we evaluated the transcriptional profiles of MDSCs in tumor-bearing mice 7 . Gene expression profiles in NBM MDSCs did not correlate with those of neutrophils and monocytes from tumor-free mice but showed correlations with those of cells from tumor-bearing mice (Supplementary Fig. 3c ). Notably, 'antimicrobial response' was the most prominent network found by IPA in NBM MDSCs (Supplementary Fig. 3d ). NBM PMN-MDSCs exhibited more killing of Escherichia coli and Candida albicans than did AM neutrophils, and NBM M-MDSCs were more potent in killing E. coli than were AM monocytes ( Supplementary Fig. 4a,b) .
Our experiments indicated that NBM M-MDSCs and PMN-MDSCs used different mechanisms of immunosuppression. Upregulation of Nos2 and nitric oxide (NO) was responsible for suppression by M-MDSCs ( Supplementary Fig. 5a,b) , whereas upregulation of S100A9 and S100A8 (S100A9/A8) was responsible for suppression by NBM PMN-MDSCs ( Fig. 1f-h) . In the absence of these proteins in S100A9-knockout (KO) mice 8 , NBM neutrophils lacked suppressive activity, whereas NBM M-MDSCs retained this activity ( Fig. 1h) . Although S100A9/A8 are known to associate with MDSCs, the specific mechanisms by which these proteins affect the suppressive activity of MDSCs were unclear. On the basis of gene profiling data, we focused on Ptges, which is required for terminal PGE2 synthesis 9 . Upregulation of Ptges in NBM PMN-MDSCs was abrogated in S100A9-KO mice ( Fig. 1i) , thus suggesting that S100A9 regulates Ptges. NBM PMN-MDSCs from 7-d-old mice, but not from 3-d-old mice, produced a substantially higher amount of PGE2 than did neutrophils from AM. Notably, NBM PMN-MDSCs from S100A9-KO mice had a low amount of PGE2 similar to that in AM neutrophils ( Fig. 1j) , thus indicating that S100A9/A8 are involved in PGE2 synthesis via regulation of Ptges. In NBM PMN-MDSCs and AM neutrophils, the expression of Cox-2 (official symbol Ptgs2) was similar ( Supplementary Fig. 5c ). NBM PMN-MDSCs from Cox-2-KO mice lacking PGE2 production ( Supplementary Fig. 5d ), compared with wild-type (WT) mice, had a substantially lower ability to suppress antigen-specific T-cell proliferation ( Fig. 1k) . Thus, PMN-MDSC activity in NBM was regulated by the S100A9/A8-mediated upregulation of Ptges and PGE2 production.
The detection of immunosuppressive MDSCs in NBM between days 4 and 14 might suggest a role of microbial colonization of the gut, which takes place during this period 10 . However, treatment of pregnant mice with combinations of antibiotics that depleted gut microbiota ( Supplementary Fig. 6a,b ) did not affect the presence or suppressive activity of MDSCs ( Supplementary Fig. 6c-e ).
We hypothesized that accumulation of MDSCs in NBM might be linked with milk feeding. Hence, we tested the effect of lactoferrin (LF), a milk component with potent immunoregulatory activity 11 , on myeloid cells in vivo by treating 3-week-old mice with daily intraperitoneal (i.p.) administration of LF. Eight-day treatment resulted in an increase in suppressive MDSCs ( Fig. 2a-c) . Treatment of 6-weekold mice with LF did not induce an increase in suppressive MDSCs, thus suggesting that myeloid progenitors differ in susceptibility to LF in mice at different ages. LF mediated suppression via Nos2 and NO in M-MDSCs ( Fig. 2d,e ) and via upregulation of S100a8 and S100a9 (Fig. 2f,g) and PGE2 ( Fig. 2h) in PMN-MDSCs. Treatment of S100A9-KO mice with LF did not induce immunosuppressive PMN-MDSCs ( Fig. 2i) . In the absence of LF in LF-KO mice, the granulocytes had no suppressive activity ( Fig. 2j ) and exhibited lower S100A9 protein content ( Fig. 2k) , Ptges expression ( Fig. 2l) , and PGE2 content ( Fig. 2m ) than did PMN-MDSCs from WT NBM. Together, these data indicated that LF may be a major factor causing acquisition of immunosuppressive activity by MDSCs in NBM.
Because myeloid cells produce LF ( Supplementary Fig. 7a ), we sought to determine the source of LF that drives MDSC accumulation by performing cross-fostering experiments. Cross-fostering of WT mice with LF-KO surrogates did not result in generation of immunosuppressive PMN-MDSCs. In contrast, cross-fostering of LF-KO NBM with WT mice generated immunosuppressive PMN-MDSCs ( Supplementary Fig. 7b ). No differences in the total number of CD11b + Ly6C lo Ly6G + cells were found (Supplementary Fig. 7c ). These results indicated that LF in milk has a role in MDSC generation.
We hypothesized that MDSCs might be important for the control of inflammation associated with early microbial colonization in neonates. One of the manifestations of pathological inflammation in neonates is necrotizing enterocolitis (NEC), which is characterized by acute intestinal injury with an associated systemic inflammatory response that may result from the establishment of gut microbiota 12 . NEC develops in 7-11% of infants with birth weights <1,500 g, termed very low weight (VLW) infants. The estimated mortality rate due to NEC is nearly 30% and approaches 100% among those with the most severe form, NEC totalis. Abnormalities in immune responses have been suggested to play a critical role in the development of NEC 13 . We investigated differences in MDSCs from the peripheral blood of normal weight (NW) (>2,500 g) or VLW (<1,500 g) newborn infants. In peripheral blood mononuclear cells (PBMCs), healthy adults had very few cells with the phenotype and morphology of PMN-MDSCs (CD11b + CD14 − CD15 + ) or M-MDSCs (CD11b + CD14 + HLA-DR −/lo CD15 − ) ( Fig. 3a and Supplementary  Fig. 8 ). The frequencies of MDSCs in NW infants were substantially higher than those in adults and VLW babies ( Fig. 3a) . MDSCs from NW infants had more potent suppressive activity than did cells from VLW babies ( Fig. 3b) . To verify these findings, we evaluated the presence of LOX-1 + neutrophils in infants. In cancer patients, LOX-1 + CD15 + neutrophils have been found to represent a population of PMN-MDSCs 14 . Only LOX-1 + but not LOX-1 − neutrophils from NW infants suppressed T cell function ( Fig. 3c) . In infants, the proportion of LOX-1 + PMN-MDSCs was much higher than that in adults ( Fig. 3d) , and the frequency of these cells was lower in VLW than in NW infants ( Fig. 3e) . Treatment with the NOS2 inhibitor LNMA, but not reactive oxygen species (ROS) inhibitors, cancelled the suppressive activity of M-MDSCs ( Fig. 3f) . M-MDSCs from NW infants but not from VLW infants had higher NOS2 expression ( Fig. 3g ) and produced more nitrites (Fig. 3h ) than did adult monocytes. PMN-MDSCs from NW infants had markedly higher production of PGE2 ( Fig. 3i ) and expression of S100A9 mRNA ( Fig. 3j) , S100A9 protein (Fig. 3k) , and LTF mRNA ( Fig. 3l ) than did cells from adults and VLW infants. MDSCs from NW and VLW neonates had higher antibacterial activity than did neutrophils and monocytes from adults ( Supplementary Fig. 9 ). NW infants fed with breast milk had higher levels of LOX-1 + PMN-MDSCs than did infants who received formula lacking LF ( Fig. 3m) .
We next asked whether MDSCs might be important in NEC. We used a gavage/hypoxia experimental model of NEC 15 , which manifests as inflammatory gut injury of varying intensity (Fig. 4a ). Although this model, like other models of NEC, cannot fully recapitulate human disease, it generates conditions (intestinal necrosis and inflammation) similar to those observed in humans. Induction of NEC in 1-d-old mice with NBM (with no MDSCs present) caused much more severe inflammation than that in 4-day-old mice with NBM (with MDSCs present), which manifested as higher intestine permeability (Fig. 4b) , higher inflammation scores (Fig. 4c) , and shorter survival times (Fig. 4d) . The differences in bacterial load were small but significant (P = 0.018) (Fig. 4e) .
To selectively deplete MDSCs in these mice, we used an agonistic antibody to TRAIL-R (DR5ab) [16] [17] [18] . PMN-MDSCs in NBM had higher expression of DR5 than did neutrophils from AM ( Supplementary  Fig. 10a ). The population of MDSCs in the lamina propria (LP) was substantially lower in DR5ab-treated cells than in control cells ( Supplementary Fig. 10b and Fig. 4f ). DR5ab significantly (P = 0.03) shortened survival ( Fig. 4g) and increased inflammation scores ( Fig. 4h) and intestine permeability (Fig. 4i) . Moreover, this treatment resulted in a small but significant (P = 0.045) increase in bacterial load in the intestine (Fig. 4j) and blood (Fig. 4k) . S100A9-KO mice were much more sensitive than WT mice to NEC induction (Supplementary Fig. 10c) , thus indicating the important role of S100A9 in PMN-MDSC protection in NEC. We next tested the effects of transfer of MDSCs from NBM on NEC development. After transfer to mice with NEC, MDSCs were readily detectable in the intestine (Supplementary Fig. 10d,e) . MDSCs from NBM elicited a decrease in inflammation scores (Fig. 4l) and intestinal permeability (Fig. 4m) . In contrast, Gr-1 + cells from AM had no effect on gut inflammation (Fig. 4l,m) affect the survival of mice with NEC. In contrast, MDSCs from NBM substantially prolonged survival (Fig. 4n) . Transfer of MDSCs from NBM decreased the bacterial load in both the intestine and blood. However, no differences in the effects of MDSC and Gr-1 + cells from AM on bacterial load were detected (Fig. 4o) .
Thus, it appears that the antibacterial effect of MDSCs is not a major factor in their effect on NEC. To confirm this possibility, we used Rag1-KO mice lacking T and B cells. In agreement with findings from previous reports 19 , NEC in Rag1-KO mice had lower inflammation and longer survival times than did WT mice ( Supplementary  Fig. 10f-i) . However, no differences in bacterial load were evident (Supplementary Fig. 10j,k) . Depletion of MDSCs in Rag1-KO mice ( Supplementary Fig. 10l and Fig. 4p ) did not affect the inflammation scores (Fig. 4q) , intestine permeability (Fig. 4r) , or survival of the mice (Fig. 4s) . Depletion of MDSCs did not affect the bacterial load in the intestine or blood in Rag1-KO mice ( Supplementary Fig. 10m) .
We then induced NEC in Rag1-KO mice and performed i.p. Fig. 11a ) and intestinal permeability ( Supplementary Fig. 11b) , and decreased survival of mice (Supplementary Fig. 11c ). Administration of MDSCs abrogated these effects (Supplementary Fig. 11a-c) . Although T cell transfer had a strong effect on mouse survival, it did not affect bacterial load. MDSCs caused a decrease in bacterial load only when mice received T cell transfer (Supplementary Fig. 11d) , possibly as a result of decreased NEC severity. Thus, these results indicated that the effect of MDSCs on NEC was mediated via inhibition of T cells.
transfer of MDSCs and CD4 + T cells. Transfer of T cells increased inflammation (Supplementary
Induction of NEC was associated with the upregulation of type 17 helper T (T H 17) cells (IL-17A + and Rorγt + ) in the small intestine. Administration of myeloid cells from AM did not affect that frequency, whereas MDSC from NBM considerably decreased it. MDSCs increased the frequency of Foxp3 + regulatory T cells (Supplementary Fig. 11e ).
LF treatment of WT mice with NEC resulted in the accumulation of MDSCs in the LP (Supplementary Fig. 12a ). This effect was associated with decreased intestinal permeability ( Supplementary  Fig. 12b ) and inflammation (Supplementary Fig. 12c) , and prolonged survival (Supplementary Fig. 12d) . LF decreased the bacterial load in both the intestine and the blood circulation ( Supplementary  Fig. 12e) . In sharp contrast, administration of LF to Rag1-KO mice did not affect the severity of NEC (Supplementary Fig. 12f-h) . Administration of T cells enhanced NEC, whereas LF abrogated T cell-induced NEC. Administration of LF had a similar antibacterial affect in mice with or without T cell transfer ( Supplementary  Fig. 12i ). Administration of LF recapitulated the effect of MDSC by downregulating intestinal T H 17 and upregulating regulatory T cells (Supplementary Fig. 12j) .
Thus, in this report, we described the presence of immunosuppressive MDSCs in healthy mice and humans during the first weeks of life. Most of the cells had the phenotype of PMN-MDSCs, a finding consistent with the previously reported elevated numbers of granulocytic MDSCs in infants in the first month of life 20 . However, the presence of MDSCs was not associated with greater myelopoiesis in NBM, because the highest presence of myeloid cells was observed during the first 3 d of life, whereas the immunosuppressive activity of these cells was observed only after day 4. Granulocytes and monocytes from PM lacked suppressive activity. Our data suggested that LF in milk may be responsible for the acquisition of a suppressive phenotype by MDSCs. The suppressive activity of M-MDSCs was mediated by LF-induced NO production, whereas the suppressive activity of PMN-MDSCs involved S100A9-mediated upregulation of PGE2. Our findings were consistent with a report in humans indicating that LF in the presence of GM-CSF increases S100A9 production 21 . S100A9/A8 proteins have previously been implicated in the regulation of MDSC expansion [22] [23] [24] . However, their role in MDSC-mediated suppression was previously unclear. S100A9/A8 in human neutrophils are arachidonic acid (AA)binding proteins that serve as an intermediate intracellular reservoir for AA and thus modulate the activities of AA-metabolizing enzymes. Higher AA concentrations favor PGE2 production over leukotrienes in neutrophils. This process is mediated by phospholipase A2, which is involved in the Cox-2-mediated generation of PGE2 via microsomal Ptges 25 . Our experiments with S100A9/A8-KO mice demonstrated that Ptges expression and PGE2 production are downstream of S100A9/A8. PGE2 directly inhibits the proliferation of T cells via upregulation of cyclic AMP 26 . The effect of LF is cell type dependent, because previous reports have demonstrated that LF negatively regulates PGE2 production in amniotic fluid, enterocytes, and chondrocytes [27] [28] [29] . However, these cells lack S100A9/A8 proteins.
We suggest that the presence of MDSCs in newborns may be one mechanism controlling the inflammatory response during the microbial colonization of the gut and lungs. Our data demonstrate the role of MDSCs under steady-state conditions and provide a mechanism for their generation, which appears to be distinct from that involved in cancer. Our results suggest that MDSCs may be used as a potential therapeutic option for treating infants with NEC.
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Analysis of MDSCs.
Mouse bone marrow cells were harvested through femoral-bone flushing and filtered through a cell strainer (80-ìm pore size; Corning). Spleens were mechanically dissociated and filtered. BM cells were cultured in RPMI 1640 medium supplemented with 10% FBS, 20 ng/ml GM-CSF, 20 ng/ml IL-6, and 50 µM 2-ME. The cultures were maintained at 37 °C in a 5% CO 2 humidified atmosphere in 24-well plates. Medium was refreshed on day 3, and cells were analyzed by flow cytometry on day 6. For flow cytometry, red blood cells were lysed in ACK buffer, and cells were stained with the following antibodies: anti-CD11b (BV421, BD), anti-Ly6C (PeCy7, BD), anti-Ly6G (FITC, BD), and Aqua live/dead (Life Technologies) (Catalog and clone numbers are provided in Supplementary Fig. 1) . Examples of gating are provided in Supplementary Figure 13 . For PMN-MDSC isolation, cells were labeled with biotinylated anti-Ly6G (Miltenyi), incubated with streptavidin microbeads (Miltenyi), and separated on MACS Columns (Miltenyi). Two passages on columns were done to maximize cell purity. For M-MDSC isolation, CD11b + Ly6C high Ly6G − cells were sorted on a MoFlo AStrios instrument (Beckman Coulter). All antibodies were obtained from BD Pharmingen. Cell Aqua live/dead (Life Technologies) was used to exclude dead cells. For S100A9 intracellular staining, cells were fixed and permeabilized with CytoFix/ CytoPerm solution (BD) according to the manufacturer's instructions, and anti-S100A9 (A647, BD) was used at a 1:200 dilution. ROS were evaluated with DCFDA (Abcam) staining.
MDSC suppression assay. PMN-MDSCs were plated in U-bottom 96-well plates (3 replicates) in RMPI with 10% FBS and cocultured at different ratios with splenocytes from Pmel or OT-1 transgenic mice in the presence of cognate peptides: OT-1, SIINFEKL; Pmel, EGSRNQDWL. Cells were incubated for 48 h, and then 3 H[thymidine] (PerkinElmer) was added (1 µl/well) and incubated overnight. Samples were counted with a TopCount NXT instrument (PerkinElmer). To evaluate M-MDSC suppressive activity, sorted CD3 + T cells from the spleen were labeled with CFSE (2 µM) (Invitrogen), stimulated with anti-CD3 (5 µg/ml)-coated plates and soluble anti-CD28 (1 µg/mL) (eBioscience), and cultured alone or with M-MDSCs at different ratios for 3 d. Cells were then stained with anti-CD4-PE-Cy5 and anti-CD8a-PE, and T-cell proliferation was analyzed by flow cytometry.
RNA-sequencing data analysis. PMN-MDSCs and M-MDSCs from spleens of neonatal (7 d old) and adult mice (6 to 8 weeks old) were enriched with CD11b-beads and then sorted on a FACSAria cell sorter (BD Bioscience), on the basis of the CD11b + Ly6C int Ly6G + phenotype for PMN-MDSCs and CD11b + Ly6C high Ly6G − for M-MDSCs. The sorting purity was >95%. RNA sequencing was performed on the Illumina Hiseq 2500 platform. A VAHTS Total RNA-Seq Library Preparation Kit (Vazyme Biotech) was used for library preparation. Single-end-read runs were used with read lengths up to 50 bp in high-output mode and 30 million total read counts. Data were analyzed in RSEM v1.2.12 software 30 against the mm10 genome, and genelevel read counts and RPKM values on the gene level were estimated for the ensemble transcriptome. Samples with at least 80% aligned reads were analyzed. DESeq2 (ref. 31 ) was used to estimate the significance between any two experimental groups. Overall changes were considered significant at an FDR <5% threshold, and an additional threshold of fold change (>5) was used to generate the final gene set. Gene set enrichment analysis was done with Qiagen's Ingenuity Pathway Analysis software (IPA; http://www.qiagen.com/ ingenuity/) with the 'functions' , 'canonical pathways' , 'upstream regulators' , and 'networks' options. Gene overlap between microarray and RNA-seq data was assessed on the basis of Entrez IDs and Pearson correlation coefficients calculated between any pair of samples. Each microarray sample correlation value was then normalized to the Pearson correlation versus average RNAseq profile. RNA-seq data have been deposited in the GEO data repository (accession number GSE97993).
Quantitative real-time PCR (qRT-PCR).
RNA was extracted with a Total RNA Kit I (Omega) according to the manufacturer's instructions. Primer sequences are listed in Supplementary Table 3. ELISA. Cells were cultured 24 h at 2 × 106/ml in RPMI with 10% FBS. PGE2, S100A9 or LF ELISA kits (Invitrogen) were used to measure the amounts of corresponding proteins in the cell lysates from 24-h cultures of MDSCs.
LF treatment.
For in vivo experiments, 3-week-old WT and S100A9-KO mice were treated with LF (Sigma Aldrich) (5 mg/mouse i.p. in PBS (vehicle) daily for 8 d), PBS was used as a vehicle control. For in vitro treatment, mouse BM cells or cord blood mononuclear cells from VLW babies were cultured in the presence of GM-CSF and IL-6, in the presence or absence of LF protein (700 µg/ml) for 6 d.
Allergy-induced airway-inflammation mouse model. BALB/C mice at different ages were intraperitoneally sensitized with 5 µg/g OVA (grade V, Sigma-Aldrich) emulsified in 200 µg/g of aluminum hydroxide (ThermoImject alum) on days 0 and 7, then intranasally challenged with OVA (5 µg/µl of PBS) once on day 17 to 21. One day after the last challenge, mice were sacrificed, and lung inflammation was examined 32 
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